Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Article Abstract:

The clinical course of a patient with multiple sclerosis in whom progressive multifocal leukoencephalopathy (PML), an opportunistic viral infection of the central nervous system, developed during treatment with interferon beta-1a and a selective adhesion-molecule blocker, natalizumab, is described. The patient was treated with systematic cytarabine, and it was found that after two months the patient's condition had improved.

Author: Bollen, Andrew W., Langer-Gould, Annette, Atlas, Scott W., Green, Ari J., Pelletier, Daniel

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

Article Abstract:

Progressive multifocal leukoencephalopathy (PML), a demyelinating disease of the central nervous system (CNS), is associated with high rates of morbidity and mortality and occurs almost exclusively in immunocompromised patients. A trial was conducted to test the safety and efficacy of natalizumab in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis.

Author: Tyler, Kenneth L., Kleinschmidt-DeMasters, B. K.
Health aspects, Interferon beta

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

Article Abstract:

The relationship between natalizumab therapy and progressive multifocal leukoencephalopathy (PML), which is an opportunistic, infectious, demyelinating brain disorder associated with impaired T-cell function, is illustrated. Polymavirus replication leading to PML, which is a life threatening disorder, can occur in patients who receive natalizumab.

Author: Rutgeerts, Paul, Assche, Gert Van, Ranst, Marc Van, Sciot, Raf, Dubois, Benedicte, Vermeire, Severine, Noman, Maja, Verbeeck, Jannick, Geboes, Karel, Robberecht, Wim
Crohn's disease

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, Case studies, Drug therapy, Multiple sclerosis, Dosage and administration, Leukoencephalopathy, Progressive multifocal, Progressive multifocal leukoencephalopathy, Natalizumab (Medication)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.